| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 9.38e-10 | 37 | 107 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.14e-09 | 38 | 107 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.81e-09 | 11 | 107 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 7.75e-09 | 14 | 107 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.64e-08 | 21 | 107 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.53e-06 | 37 | 107 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.75e-06 | 38 | 107 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.63e-06 | 46 | 107 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | isomerase activity | 9.13e-06 | 192 | 107 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 6.61e-05 | 79 | 107 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 IMPA1 TNS2 ERVK-7 ERVK-10 FAAH BPNT1 PTPN9 PLCH2 ERVK-8 PLA2G2A PLCH1 ERVK-11 PPTC7 | 1.03e-04 | 807 | 107 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ADAM23 PRSS12 ERVK-7 ERVK-10 F11 ERVK-8 ERVK-18 ERVK-19 ERVK-25 | 1.06e-04 | 430 | 107 | 10 | GO:0004175 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.48e-04 | 50 | 107 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.69e-04 | 152 | 107 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.86e-04 | 53 | 107 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ADAM23 PRSS12 NPEPPS ERVK-7 ERMP1 ERVK-10 F11 ERVK-8 ERVK-18 ERVK-19 ERVK-25 | 2.00e-04 | 654 | 107 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | protein homodimerization activity | ERVK-6 CEBPB GALM IMPA1 PANK3 HLA-E DAXX CUBN AXIN1 TENM1 USF1 KYNU TOP2A | 4.16e-04 | 815 | 107 | 13 | GO:0042803 |
| GeneOntologyMolecularFunction | poly(A) binding | 4.94e-04 | 29 | 107 | 3 | GO:0008143 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.28e-04 | 262 | 107 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 8.30e-04 | 136 | 107 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 8.30e-04 | 136 | 107 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 CLDN18 ERVK-7 ERVK-10 TECTA FBN1 CSRP2 ERVK-8 ERVK-18 ERVK-19 ERVK-25 PLP1 KRT25 | 9.55e-04 | 891 | 107 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | poly-purine tract binding | 1.02e-03 | 37 | 107 | 3 | GO:0070717 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.28e-03 | 40 | 107 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | racemase and epimerase activity, acting on carbohydrates and derivatives | 1.52e-03 | 11 | 107 | 2 | GO:0016857 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 IMPA1 ZSWIM5 CYP7A1 NPEPPS ZDBF2 ERVK-7 ERVK-10 TF ADH7 PAH ERVK-8 ERVK-19 ERVK-11 PCK2 | 1.67e-03 | 1189 | 107 | 15 | GO:0046914 |
| GeneOntologyMolecularFunction | protein dimerization activity | ERVK-6 CEBPB GALM IMPA1 PANK3 HLA-E DAXX CUBN AXIN1 TENM1 USF1 KRT25 KYNU TOP2A NPAS2 | 1.90e-03 | 1205 | 107 | 15 | GO:0046983 |
| GeneOntologyMolecularFunction | kinesin binding | 3.21e-03 | 55 | 107 | 3 | GO:0019894 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.42e-03 | 115 | 107 | 4 | GO:0004497 | |
| GeneOntologyBiologicalProcess | DNA integration | 4.26e-09 | 13 | 107 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 2.49e-07 | 83 | 107 | 7 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 4.90e-06 | 48 | 107 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 1.11e-05 | 9 | 107 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | DNA replication | 3.62e-05 | 312 | 107 | 9 | GO:0006260 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 4.00e-05 | 178 | 107 | 7 | GO:0006261 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 4.07e-05 | 244 | 107 | 8 | GO:0006006 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 4.41e-05 | 38 | 107 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | RGPD4 RGPD2 IMPA1 CYP7A1 GFI1 PAH PLA2G2A DSEL PLP1 PGM2 KYNU PCK2 PPTC7 | 4.80e-05 | 676 | 107 | 13 | GO:0044283 |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.18e-04 | 284 | 107 | 8 | GO:0019318 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 1.43e-04 | 218 | 107 | 7 | GO:0071897 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.77e-04 | 54 | 107 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 2.14e-04 | 310 | 107 | 8 | GO:0005996 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.07e-05 | 9 | 107 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 4.56e-05 | 14 | 107 | 3 | GO:0072379 | |
| Domain | DUF2012 | 1.73e-04 | 4 | 101 | 2 | PF09430 | |
| Domain | Inositol_monoP_metal-BS | 1.73e-04 | 4 | 101 | 2 | IPR020583 | |
| Domain | DUF2012 | 1.73e-04 | 4 | 101 | 2 | IPR019008 | |
| Domain | Inositol_monophosphatase-like | 2.86e-04 | 5 | 101 | 2 | IPR000760 | |
| Domain | Inositol_P | 2.86e-04 | 5 | 101 | 2 | PF00459 | |
| Domain | Inositol_monophosphatase_CS | 2.86e-04 | 5 | 101 | 2 | IPR020550 | |
| Domain | IMP_1 | 2.86e-04 | 5 | 101 | 2 | PS00629 | |
| Domain | IMP_2 | 2.86e-04 | 5 | 101 | 2 | PS00630 | |
| Domain | FAD-bd | 4.28e-04 | 6 | 101 | 2 | IPR002938 | |
| Domain | FAD_binding_3 | 4.28e-04 | 6 | 101 | 2 | PF01494 | |
| Domain | Rab_bind | 5.97e-04 | 7 | 101 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 5.97e-04 | 7 | 101 | 2 | IPR032023 | |
| Domain | TPR | 6.78e-04 | 129 | 101 | 5 | SM00028 | |
| Domain | TPR_repeat | 7.79e-04 | 133 | 101 | 5 | IPR019734 | |
| Domain | Carb-bd-like_fold | 7.94e-04 | 8 | 101 | 2 | IPR013784 | |
| Domain | RRM_1 | 9.35e-04 | 208 | 101 | 6 | PF00076 | |
| Domain | RRM | 1.16e-03 | 217 | 101 | 6 | SM00360 | |
| Domain | Hud_Sxl_RNA | 1.27e-03 | 10 | 101 | 2 | IPR002343 | |
| Domain | - | 1.27e-03 | 10 | 101 | 2 | 1.10.220.60 | |
| Domain | TPR-contain_dom | 1.33e-03 | 150 | 101 | 5 | IPR013026 | |
| Domain | RRM_dom | 1.46e-03 | 227 | 101 | 6 | IPR000504 | |
| Domain | Grip | 1.54e-03 | 11 | 101 | 2 | SM00755 | |
| Domain | GRIP | 1.54e-03 | 11 | 101 | 2 | PF01465 | |
| Domain | RRM | 1.56e-03 | 230 | 101 | 6 | PS50102 | |
| Domain | Ran_BP1 | 1.84e-03 | 12 | 101 | 2 | PF00638 | |
| Domain | RANBD1 | 1.84e-03 | 12 | 101 | 2 | PS50196 | |
| Domain | GRIP_dom | 1.84e-03 | 12 | 101 | 2 | IPR000237 | |
| Domain | GRIP | 1.84e-03 | 12 | 101 | 2 | PS50913 | |
| Domain | TPR_REGION | 2.03e-03 | 165 | 101 | 5 | PS50293 | |
| Domain | TPR | 2.03e-03 | 165 | 101 | 5 | PS50005 | |
| Domain | - | 2.11e-03 | 244 | 101 | 6 | 3.30.70.330 | |
| Domain | CarboxyPept_regulatory_dom | 2.17e-03 | 13 | 101 | 2 | IPR014766 | |
| Domain | RanBD | 2.17e-03 | 13 | 101 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 2.17e-03 | 13 | 101 | 2 | IPR000156 | |
| Domain | - | 2.17e-03 | 13 | 101 | 2 | 2.60.40.1120 | |
| Domain | Nucleotide-bd_a/b_plait | 2.78e-03 | 258 | 101 | 6 | IPR012677 | |
| Domain | EF-hand_like | 2.90e-03 | 15 | 101 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 2.90e-03 | 15 | 101 | 2 | PF00387 | |
| Domain | PLCYc | 2.90e-03 | 15 | 101 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.90e-03 | 15 | 101 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 2.90e-03 | 15 | 101 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 2.90e-03 | 15 | 101 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.90e-03 | 15 | 101 | 2 | IPR015359 | |
| Domain | KRAB | 3.30e-03 | 358 | 101 | 7 | PS50805 | |
| Domain | KRAB | 3.30e-03 | 358 | 101 | 7 | PF01352 | |
| Domain | CarboxyPept-like_regulatory | 3.73e-03 | 17 | 101 | 2 | IPR008969 | |
| Domain | KRAB | 3.90e-03 | 369 | 101 | 7 | SM00349 | |
| Domain | KRAB | 3.96e-03 | 370 | 101 | 7 | IPR001909 | |
| Domain | PI-PLC-X | 4.19e-03 | 18 | 101 | 2 | PF00388 | |
| Domain | PLCXc | 4.19e-03 | 18 | 101 | 2 | SM00148 | |
| Domain | Cyclophilin-type_PPIase_CS | 4.66e-03 | 19 | 101 | 2 | IPR020892 | |
| Domain | PIPLC_X_DOMAIN | 4.66e-03 | 19 | 101 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.66e-03 | 19 | 101 | 2 | IPR000909 | |
| Domain | - | 5.33e-03 | 391 | 101 | 7 | 2.30.29.30 | |
| Domain | - | 5.34e-03 | 207 | 101 | 5 | 1.25.40.10 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 2.16e-05 | 62 | 77 | 5 | M11521 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 4.39e-10 | 5 | 108 | 4 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-11 | 5.93e-10 | 94 | 108 | 8 | 21542922 |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 10516026 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.16e-07 | 4 | 108 | 3 | 10469592 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 7983737 | ||
| Pubmed | 2.60e-07 | 18 | 108 | 4 | 18664271 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | NPEPPS CDKN2AIP CUBN ZNF251 NOMO1 PTPN9 RBM25 CCDC47 CSRP2 MICAL3 RPA1 KIF2C | 1.23e-06 | 670 | 108 | 12 | 22990118 |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.41e-06 | 9 | 108 | 3 | 18394993 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.41e-06 | 9 | 108 | 3 | 36261522 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | PRSS12 NPEPPS RBMS1 RBMS2 TF ADH7 AHSG HNRNPA0 WDR1 PLCH1 RPA1 PGM2 | 3.05e-06 | 732 | 108 | 12 | 34732716 |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 4.72e-06 | 11 | 108 | 3 | 32820719 | |
| Pubmed | 4.91e-06 | 403 | 108 | 9 | 35253629 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 14557543 | ||
| Pubmed | IMPA1 PDHA2 NPEPPS RFC1 AXIN1 RBM25 MICAL2 HNRNPA0 PPIE WDR1 CTTN RPA1 TOP2A PHLDB2 KLC1 | 7.39e-06 | 1247 | 108 | 15 | 27684187 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 RGPD2 NPEPPS NASP RBM25 HNRNPA0 CTTN RPA1 TOP2A PCK2 VDAC3 | 7.41e-06 | 665 | 108 | 11 | 30457570 |
| Pubmed | RGPD4 RGPD2 NPEPPS GSN PTPN9 PDE4DIP WDR1 CTTN RPA1 PLP1 PHLDB2 KLC1 KIF2C | 9.44e-06 | 963 | 108 | 13 | 28671696 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11606717 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38096518 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8041632 | ||
| Pubmed | Identification of a novel class of mammalian phosphoinositol-specific phospholipase C enzymes. | 9.55e-06 | 2 | 108 | 2 | 15583837 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21820158 | ||
| Pubmed | Structures and comparison of genomic and complementary DNAs of mouse MSSP, a c-Myc binding protein. | 9.55e-06 | 2 | 108 | 2 | 10639566 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 9.55e-06 | 2 | 108 | 2 | 9460924 | |
| Pubmed | Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta. | 9.55e-06 | 2 | 108 | 2 | 19690170 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22955269 | ||
| Pubmed | Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death. | 9.55e-06 | 2 | 108 | 2 | 17210684 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 9.55e-06 | 2 | 108 | 2 | 11672541 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22905201 | ||
| Pubmed | Identification of interaction partners for the basic-helix-loop-helix protein E47. | 1.03e-05 | 14 | 108 | 3 | 9050988 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | NASP DAXX RFC1 FBN1 NOMO2 PDE4DIP ZNF667 HNRNPA0 PLA2G2A HERC3 WDR1 RPA1 KLC1 KIF2C | 1.04e-05 | 1124 | 108 | 14 | 21900206 |
| Pubmed | Genetic characterization of important mouse strains used in cancer research. | 1.29e-05 | 15 | 108 | 3 | 75870 | |
| Pubmed | 1.49e-05 | 99 | 108 | 5 | 27746211 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NPEPPS RBMS2 NASP RABGAP1 RFC1 GSN PPIF BPNT1 CCDC47 CSRP2 WDR1 CTTN TOP2A PHLDB2 KIF2C | 2.17e-05 | 1367 | 108 | 15 | 32687490 |
| Pubmed | 2.30e-05 | 18 | 108 | 3 | 4353891 | ||
| Pubmed | 2.72e-05 | 19 | 108 | 3 | 20504901 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 36011023 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 9971820 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 21385839 | ||
| Pubmed | C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells. | 2.86e-05 | 3 | 108 | 2 | 20797423 | |
| Pubmed | SENP2 suppresses browning of white adipose tissues by de-conjugating SUMO from C/EBPβ. | 2.86e-05 | 3 | 108 | 2 | 35196497 | |
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.86e-05 | 3 | 108 | 2 | 25576386 | |
| Pubmed | 5.15e-05 | 65 | 108 | 4 | 32521226 | ||
| Pubmed | The MICAL proteins and rab1: a possible link to the cytoskeleton? | 5.71e-05 | 4 | 108 | 2 | 15694364 | |
| Pubmed | Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC. | 5.71e-05 | 4 | 108 | 2 | 17254575 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 5.71e-05 | 4 | 108 | 2 | 31833031 | |
| Pubmed | Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. | 5.71e-05 | 4 | 108 | 2 | 24440334 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 9267806 | ||
| Pubmed | 5.82e-05 | 552 | 108 | 9 | 36293380 | ||
| Pubmed | 7.98e-05 | 330 | 108 | 7 | 32529326 | ||
| Pubmed | 8.53e-05 | 451 | 108 | 8 | 36168627 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 12110185 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 9.50e-05 | 5 | 108 | 2 | 11401426 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 8464732 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 23418544 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 16760430 | ||
| Pubmed | 9.61e-05 | 340 | 108 | 7 | 24332808 | ||
| Pubmed | ADAM23 ZSWIM5 RBMS1 CDKN2AIP VTCN1 ERMP1 ERVK-10 TRANK1 CSRP2 TENM1 MICAL3 ERVK-25 PCK2 | 1.03e-04 | 1215 | 108 | 13 | 15146197 | |
| Pubmed | 1.05e-04 | 149 | 108 | 5 | 25184681 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 1.09e-04 | 742 | 108 | 10 | 26871637 | |
| Pubmed | 1.09e-04 | 347 | 108 | 7 | 16033648 | ||
| Pubmed | 1.31e-04 | 156 | 108 | 5 | 37108203 | ||
| Pubmed | NASP C12orf57 GSN PPIF RBM25 CCDC47 CSRP2 PPIE KAZN WDR1 VDAC3 | 1.35e-04 | 916 | 108 | 11 | 32203420 | |
| Pubmed | Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. | 1.42e-04 | 6 | 108 | 2 | 17417626 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 36862552 | ||
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 15063128 | ||
| Pubmed | Identification and genetic monitoring of mouse inbred strains using biochemical polymorphisms. | 1.42e-04 | 6 | 108 | 2 | 926748 | |
| Pubmed | NPEPPS RBM28 RFC1 GSN CCDC47 CSRP2 HNRNPA0 MICAL3 WDR1 CTTN RPA1 TOP2A PCK2 VDAC3 | 1.50e-04 | 1440 | 108 | 14 | 30833792 | |
| Pubmed | 1.54e-04 | 86 | 108 | 4 | 37253089 | ||
| Pubmed | CEBPB NPEPPS CDKN2AIP RBM28 RFC1 GFI1 GSN HNRNPA0 USF1 RPA1 TOP2A KIF2C | 1.66e-04 | 1103 | 108 | 12 | 34189442 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.66e-04 | 497 | 108 | 8 | 36774506 | |
| Pubmed | 1.77e-04 | 35 | 108 | 3 | 22688191 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPRN DAXX RBM28 GSN RBM25 HNRNPA0 WDR1 CTTN RPA1 TOP2A KIF2C | 1.83e-04 | 949 | 108 | 11 | 36574265 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RBMS1 CDKN2AIP RBMS2 ZDBF2 RBM28 RFC1 RBM25 HNRNPA0 CTTN TOP2A VDAC3 | 1.92e-04 | 954 | 108 | 11 | 36373674 |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 17332754 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.99e-04 | 7 | 108 | 2 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.99e-04 | 7 | 108 | 2 | 11353387 | |
| Pubmed | Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. | 1.99e-04 | 7 | 108 | 2 | 24280982 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 30944974 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.99e-04 | 7 | 108 | 2 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.99e-04 | 7 | 108 | 2 | 17372272 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 38657106 | ||
| Pubmed | The Gpr1/Zdbf2 locus provides new paradigms for transient and dynamic genomic imprinting in mammals. | 1.99e-04 | 7 | 108 | 2 | 24589776 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 21205196 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 18949001 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 25187515 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 8603673 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 26632511 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 24403063 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 23818861 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 23213405 | ||
| Pubmed | Direct interaction between cohesin complex and DNA replication machinery. | 1.99e-04 | 7 | 108 | 2 | 16438930 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 23536549 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 16075368 | ||
| Pubmed | ATRX Promotes DNA Repair Synthesis and Sister Chromatid Exchange during Homologous Recombination. | 1.99e-04 | 7 | 108 | 2 | 29937341 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 12191015 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 22821000 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 20682751 | ||
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 6.73e-05 | 115 | 67 | 5 | 769 | |
| GeneFamily | RNA binding motif containing | 1.37e-04 | 213 | 67 | 6 | 725 | |
| GeneFamily | Phospholipases | 5.04e-04 | 42 | 67 | 3 | 467 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.27e-03 | 718 | 67 | 9 | 28 | |
| GeneFamily | LIM domain containing | 1.36e-03 | 59 | 67 | 3 | 1218 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 2.22e-03 | 19 | 67 | 2 | 909 | |
| GeneFamily | Phosphoinositide phosphatases | 6.25e-03 | 32 | 67 | 2 | 1079 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 3.96e-06 | 240 | 100 | 8 | MM3678 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | NPEPPS NASP CLSTN1 TF F11 TRANK1 CSRP2 PDE4DIP PLA2G2A PPIE PCK2 | 1.10e-05 | 567 | 100 | 11 | M16909 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.15e-05 | 199 | 100 | 7 | M5893 | |
| Coexpression | GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.19e-05 | 200 | 100 | 7 | M9554 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP | 1.19e-05 | 200 | 100 | 7 | M6524 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.72e-05 | 153 | 100 | 6 | M5588 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.93e-05 | 155 | 100 | 6 | MM1259 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 6.52e-05 | 261 | 100 | 7 | M1834 | |
| CoexpressionAtlas | e10.5_NeuroEpith_FlankLateral_top-relative-expression-ranked_500_5 | 2.61e-05 | 330 | 100 | 9 | Facebase_ST1_e10.5_NeuroEpith_FlankLateral_500_5 | |
| CoexpressionAtlas | e9.5_MaxilArch_top-relative-expression-ranked_500 | 4.25e-05 | 439 | 100 | 10 | Facebase_ST1_e9.5_MaxilArch_500 | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 1.05e-09 | 140 | 100 | 8 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | RV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 5.91e-07 | 134 | 100 | 6 | 8c4046ba1f85172915a112499e492c3efe8474c2 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-06 | 186 | 100 | 6 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.63e-06 | 191 | 100 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.77e-06 | 192 | 100 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 5.06e-06 | 194 | 100 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.06e-06 | 194 | 100 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 5.06e-06 | 194 | 100 | 6 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.22e-06 | 195 | 100 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 5.37e-06 | 196 | 100 | 6 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-06 | 197 | 100 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | control-B_cell|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.80e-05 | 157 | 100 | 5 | 1269b55f2ef6a493f6116b131cc5cc7b8897d63e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.87e-05 | 168 | 100 | 5 | d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.98e-05 | 169 | 100 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.09e-05 | 170 | 100 | 5 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-05 | 172 | 100 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-05 | 174 | 100 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-05 | 177 | 100 | 5 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 100 | 5 | f99500c4a590e5152ded5862690f7fa614d64a80 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 100 | 5 | 7d61466181ab73088de3ec8a129d7cfa8cac7ecc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 100 | 5 | 6c98ce32cb55cf9cee557449e41b23bdb22f5efd | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 5.23e-05 | 179 | 100 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.51e-05 | 181 | 100 | 5 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 182 | 100 | 5 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.96e-05 | 184 | 100 | 5 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 6.11e-05 | 185 | 100 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 6.11e-05 | 185 | 100 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 187 | 100 | 5 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 187 | 100 | 5 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 187 | 100 | 5 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 187 | 100 | 5 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.43e-05 | 187 | 100 | 5 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 188 | 100 | 5 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | 15-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 6.59e-05 | 188 | 100 | 5 | c68ccb1c5c21d13ddac09b16e7d466f0530bbda5 | |
| ToppCell | Entopeduncular-Endothelial|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.59e-05 | 188 | 100 | 5 | 94774652fd42bad5012356672ffac8b6d2c22d37 | |
| ToppCell | 15-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 6.59e-05 | 188 | 100 | 5 | 2534684e4932c1255c24a26ca2277ac7af0a118b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 6.76e-05 | 189 | 100 | 5 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 6.76e-05 | 189 | 100 | 5 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-05 | 189 | 100 | 5 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.93e-05 | 190 | 100 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 190 | 100 | 5 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 7.28e-05 | 192 | 100 | 5 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 7.46e-05 | 193 | 100 | 5 | 06ddaeb2fd32895181e23f3f1bb3e9103e79752c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.46e-05 | 193 | 100 | 5 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 7.46e-05 | 193 | 100 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.46e-05 | 193 | 100 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 7.65e-05 | 194 | 100 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.65e-05 | 194 | 100 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 7.83e-05 | 195 | 100 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Posterior_cortex-Endothelial|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.83e-05 | 195 | 100 | 5 | 988e3449691cc228cb55e5e30355136c97b12262 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-05 | 196 | 100 | 5 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 196 | 100 | 5 | 77feb22fd0b0b1df03375da472134412e9e69c90 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.03e-05 | 196 | 100 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.22e-05 | 197 | 100 | 5 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.22e-05 | 197 | 100 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 8.22e-05 | 197 | 100 | 5 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.42e-05 | 198 | 100 | 5 | 39c90d8de44d8229843ee84b39e69be1b7d67ab4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.62e-05 | 199 | 100 | 5 | a95aa72387c9558e0316898eaa9df4de8932af1b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.62e-05 | 199 | 100 | 5 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD4+_T_naive|ICU-NoSEP / Disease, condition lineage and cell class | 8.62e-05 | 199 | 100 | 5 | 4cb6faa6ea5d6d36b9969822f572f7a7b3855dad | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.62e-05 | 199 | 100 | 5 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.62e-05 | 199 | 100 | 5 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.62e-05 | 199 | 100 | 5 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.62e-05 | 199 | 100 | 5 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.62e-05 | 199 | 100 | 5 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-05 | 199 | 100 | 5 | 67d8c7e5356f5d409d4f98e8338cf6c499fd7aee | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 8.62e-05 | 199 | 100 | 5 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 8.62e-05 | 199 | 100 | 5 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-dn_T|ICU-NoSEP / Disease, condition lineage and cell class | 8.62e-05 | 199 | 100 | 5 | 7fb211f803a8b3a2cfa9455386abea08131c6b52 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 199 | 100 | 5 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.62e-05 | 199 | 100 | 5 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-05 | 200 | 100 | 5 | 0e85c90719d9ec51a566e230c9dd2909d8df1f52 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 200 | 100 | 5 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-05 | 200 | 100 | 5 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-05 | 200 | 100 | 5 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 8.83e-05 | 200 | 100 | 5 | 6d8f6a6b3f61c529fbed1376659641030abf4f2c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-05 | 200 | 100 | 5 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 200 | 100 | 5 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 200 | 100 | 5 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-05 | 200 | 100 | 5 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-05 | 200 | 100 | 5 | 87177c973e722ac7d9ee503b9cfacd84fc67865d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 200 | 100 | 5 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 200 | 100 | 5 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-05 | 200 | 100 | 5 | cbf6a6c3db88bac37bd084a3a914b12b3af524eb | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 200 | 100 | 5 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 200 | 100 | 5 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-05 | 200 | 100 | 5 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 200 | 100 | 5 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-05 | 200 | 100 | 5 | f6cf98aad53aa8b3fa02cf874d6f7cd75530a213 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 200 | 100 | 5 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 200 | 100 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 148 | 100 | 4 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 148 | 100 | 4 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 148 | 100 | 4 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.82e-04 | 152 | 100 | 4 | 6f9c343669883618cd9c1c8921a90c34d153f303 | |
| Disease | intellectual disability (is_implicated_in) | 1.35e-04 | 30 | 98 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | Paratuberculosis | 1.62e-04 | 6 | 98 | 2 | C0030524 | |
| Disease | leukemia (is_marker_for) | 2.27e-04 | 7 | 98 | 2 | DOID:1240 (is_marker_for) | |
| Disease | Wooly hair | 2.27e-04 | 7 | 98 | 2 | C0343073 | |
| Disease | phosphatidylcholine 40:7 measurement | 8.32e-04 | 13 | 98 | 2 | EFO_0021477 | |
| Disease | susceptibility to cold sores measurement | 1.34e-03 | 65 | 98 | 3 | EFO_0008402 | |
| Disease | Adrenocortical carcinoma | 1.61e-03 | 18 | 98 | 2 | C0206686 | |
| Disease | body weight | EPHA6 RBMS1 WNT9A RABGAP1 EBF1 AXIN1 TNNI3K PTPN9 CSRP2 KAZN RPA1 | 3.11e-03 | 1261 | 98 | 11 | EFO_0004338 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKAAKDVFNKGYGFG | 11 | Q9Y277 | |
| CGFSTGYGAAVKTGK | 186 | P40394 | |
| GTKAAGSDKFCYEKL | 616 | O75077 | |
| LAKGYKGFKGNCSMT | 2096 | Q86TB3 | |
| YGLEAFVCVGTKAKG | 391 | Q8TAP6 | |
| YDCGKGPDGTNVKKS | 131 | O94985 | |
| GKASAYVFASPGCKK | 231 | O95861 | |
| GARGSSSSGGKKCYK | 46 | Q9UER7 | |
| HKTGNYKKDFLCGLG | 441 | Q7Z2K6 | |
| GASGKLQAFGFCEYK | 121 | P49756 | |
| VTEKGSKACRGFGYV | 36 | Q9NW13 | |
| DKTTNKCKGYGFVDF | 96 | P29558 | |
| KTTNKCKGYGFVDFD | 91 | Q15434 | |
| CGSNYANFELDLGKK | 156 | P43378 | |
| FGKGKSCCYRFLTKG | 306 | Q99743 | |
| KRGCGTKFLSYKFSN | 76 | P14555 | |
| KDTGGDGQDSLYKIC | 621 | Q9Y3P9 | |
| GVICDYFGKKASGNS | 596 | P56730 | |
| GSFCFKAKPGTYKVQ | 451 | Q5JPE7 | |
| RSCAGKNAVSYGKGT | 576 | Q460N3 | |
| KKSSGGKGGSYSKAE | 331 | P13747 | |
| DLRGLGAKKFYGKFC | 136 | Q7RTP6 | |
| GAKKFYGKFCAGAID | 141 | Q7RTP6 | |
| AGKEENSSGLKYKAG | 706 | Q674X7 | |
| GGGSYKCIKCSKVFS | 251 | Q99684 | |
| GSGKGTQCEKLVEKY | 386 | Q9Y6K8 | |
| YTAFSSGFLKVCGGK | 906 | Q15034 | |
| YLGTGCGKSKENAKA | 511 | Q9NXV6 | |
| EFCSDKPKSGAKYGL | 281 | Q96A33 | |
| SGYGGNSLLGKKCFA | 251 | Q16822 | |
| GQGAFGKAYLAKGKS | 11 | Q6P3R8 | |
| GSFCFKAKPGTYKVQ | 451 | Q15155 | |
| YGDKIATGSFDKTCK | 146 | Q8N136 | |
| DGKNNYPKACGKFEI | 501 | Q96G03 | |
| KIKTDNGPGYCSKAF | 706 | P63132 | |
| DGACKSGGYKSKDYG | 391 | Q7Z3Z0 | |
| KIKTDNGPGYCSKAF | 706 | P63135 | |
| KIKTDNGPGYCSKAF | 706 | Q9BXR3 | |
| SLLGKKYGETANECG | 71 | P49321 | |
| FGLCKQGDSIKAYGA | 331 | P00439 | |
| LCATGGGAYKFEKDF | 111 | Q9H999 | |
| DFRKGLLKKGACYGD | 46 | Q8NI37 | |
| KIKTDNGPGYCSKAF | 706 | Q9QC07 | |
| SKAYGASKTFGKAAG | 156 | P27694 | |
| FKIKYEAKSLACGGN | 2206 | O60494 | |
| GFKAKYSIAQCGGRV | 2326 | O60494 | |
| KGKNGAVYPKHSGFC | 291 | Q96C23 | |
| TSKFAQKYGGAEKCS | 106 | Q16527 | |
| QYGFCKATLSEKLGG | 226 | P02765 | |
| GDTDFGYGKGKCSKQ | 71 | Q96C92 | |
| YSGKKGKTGCTDINE | 1311 | P35555 | |
| SYSFCSGKGVGIKGE | 41 | O15169 | |
| LFSDDYGGKNCKKPA | 121 | P17676 | |
| EGKGKCYLKLSSNGS | 341 | P03951 | |
| TLSYKSKQFCKGTPG | 326 | Q9UH73 | |
| NGKTKTTFYCNGLKL | 416 | P22680 | |
| FKSGLKYKKGGVASG | 161 | P06396 | |
| LSKSGLKGCVYGQEA | 261 | O00519 | |
| HNGTGGKSIYGKKFD | 206 | Q9UNP9 | |
| FGSNTKNKKIYDGGA | 231 | P56856 | |
| GGKGKCNLNSGYAFE | 1066 | Q8IZU8 | |
| KATCFAYGQTGSGKT | 341 | Q99661 | |
| LSQKKFCAGGSYVGE | 521 | P55786 | |
| IKAYGFSCDGEGVLK | 66 | Q99622 | |
| CKGKQKDGTSFGEYG | 436 | Q07866 | |
| DLRGLGAKKFYGKFC | 136 | O94851 | |
| GAKKFYGKFCAGSID | 141 | O94851 | |
| PGFYKAFAGNTKCSK | 281 | Q9UF33 | |
| LGAGIALACKYKGND | 171 | P29803 | |
| FSGAGEKLFSSQCGK | 996 | Q7Z3J3 | |
| KFGKFSGKDDGSSFK | 631 | P35251 | |
| KGFSGAGEKLFSSQC | 986 | P0DJD1 | |
| YTARKGKGAFCNGQK | 131 | P29218 | |
| CFSGDGGYAKDAKMK | 1481 | Q9UKZ4 | |
| YDGKTGEKVCALGGS | 216 | O75083 | |
| LCTGEKGFGYKGSTF | 81 | P30405 | |
| NLEKKYSSLSGGKGF | 806 | Q86SQ0 | |
| KTDNGPGYCSKAFQK | 706 | P63136 | |
| QGDGYCLKLTDMKGF | 1686 | O75443 | |
| KKFQLCGSLAAYGEA | 1726 | O75443 | |
| NGKKTHKYNKCGRGF | 276 | Q5HYK9 | |
| CKKSGGKYSLNSGAV | 196 | P13682 | |
| GDKSYKHEECGKGFN | 256 | Q8NE65 | |
| KLFLSQGGYCGSGKQ | 346 | Q9P217 | |
| SCGEGFANTYGLKKH | 1021 | P0CJ78 | |
| NYLGKKSDEFNACGK | 161 | Q06732 | |
| DSFKKATLGRYGSCG | 61 | Q8TB69 | |
| GYSGAFKCLKDGAGD | 206 | P02787 | |
| ADKQSGKKRGFGFVY | 131 | Q13151 | |
| YSKGFGGKYGIDKDK | 191 | Q14247 | |
| SQKDYKTGFGGKFGV | 261 | Q14247 | |
| RAKFSANGGCGYVLK | 721 | O75038 | |
| KIKTDNGPGYCSKAF | 706 | P10266 | |
| KIKTDNGPGYCSKAF | 706 | P63133 | |
| KSCGYNGSKGKFNLE | 1656 | Q9HCK1 | |
| KIKTDNGPGYCSKAF | 706 | Q9UQG0 | |
| AKFKANGNCGYVLKP | 696 | Q4KWH8 | |
| HNGDGTYKCKFCGKA | 191 | Q08AG5 | |
| YLGKKSDEFNACGKL | 161 | Q06730 | |
| KKVTGGRNGYGAKLC | 156 | P11388 | |
| TGEKSFGCNEYGKAF | 561 | Q9BRH9 | |
| GGYLALQKSCLTKAG | 556 | Q4KMQ1 | |
| KIKDCYGLGSGQNHF | 306 | Q6P2C0 | |
| GGCGDNLKYSSKFVK | 166 | O14904 | |
| KTDNGPGYCSKAFQK | 711 | Q9WJR5 | |
| KVAAKCYQKGGAFEK | 1716 | O15050 | |
| SGSFGKVYKGRCRNK | 471 | Q59H18 | |
| CKGNKGKLGVIVSAY | 231 | Q63HR2 | |
| GTYKCYIITSKGKGN | 126 | Q7Z7D3 | |
| KGKGNANLEYKTGAF | 136 | Q7Z7D3 | |
| SGQSKGGILSKACDY | 236 | P22415 | |
| GLYCGKTLLFKNGST | 11 | Q9P055 | |
| ITKAGQAKGCYVGFD | 236 | Q16719 | |
| GNSKKGLKAYSLDAC | 2021 | Q5VU43 | |
| FGDYKTTICGKGLSA | 101 | P60201 |